Javascript must be enabled to continue!
Age, gender, and ethnicity are associated with higher all-cause mortality in hospitalized patients with heparin-induced thrombocytopenia: A nationwide analysis
View through CrossRef
Abstract
Introduction
Heparin-induced thrombocytopenia (HIT) is a life-threatening immunologic reaction to heparin exposure that is associated with substantial morbidity and mortality. Limited research is available on host-dependent risk factors, such as age, gender, and ethnicity. This study aims to characterize any association between age, gender, ethnicity, and mortality in HIT patients to better identify patient populations at increased risk.
Methods
This is a retrospective case control analysis of all-cause mortality in 72,935 patients with a diagnosis of HIT between 2016–2020. Adult patients with HIT were selected using the ICD-10 code D75.82 (HIT) for inclusion and evaluated by demographic, clinical, and hospital characteristics. Odds ratios were calculated for continuous variables using 95% confidence intervals. Multivariable logistic regression was used to ascertain the odds of binary clinical outcomes relative to patient and hospital characteristics as well as the odds of clinical outcomes over time.
Results
Our analysis indicates that hospitalized patients with HIT are at 5 times higher odds of mortality than in those without HIT (OR: 5.42, 95% CI: 5.15–5.71, p < 0.001). Our data also indicates significantly higher odds of HIT-associated mortality based on patient age, gender, and ethnicity. By age, HIT patients at the highest risk of mortality were found to be between ages 46–60 (Odds Ratio (OR): 2.60, 95% CI: 1.58–4.25), p < 0.001). By gender, females with HIT are at significantly lower odds of mortality compared to males (OR: 0.90, 95% CI: 0.82–0.99, p < 0.001). By ethnicity, Hispanic patients are at the highest risk of mortality (OR: 1.52, 95% CI: 1.31–1.77, p < 0.001), followed by black patients (OR: 1.45, 95% CI: 1.27–1.66, p < 0.001), and then Asian patients (OR: 1.31, 95% CI: 1.00-1.72, p = 0.05).
Conclusion
HIT remains a clinical diagnosis based on quantitative criteria such as thrombocytopenia relative to baseline and timing of platelet decline but does not take into consideration other clinical variables that may stratify patients by increased risk. This study elucidates the relationship between host-dependent risk factors such as age, gender, and ethnicity, on the risk of all-cause mortality associated with HIT.
Springer Science and Business Media LLC
Title: Age, gender, and ethnicity are associated with higher all-cause mortality in hospitalized patients with heparin-induced thrombocytopenia: A nationwide analysis
Description:
Abstract
Introduction
Heparin-induced thrombocytopenia (HIT) is a life-threatening immunologic reaction to heparin exposure that is associated with substantial morbidity and mortality.
Limited research is available on host-dependent risk factors, such as age, gender, and ethnicity.
This study aims to characterize any association between age, gender, ethnicity, and mortality in HIT patients to better identify patient populations at increased risk.
Methods
This is a retrospective case control analysis of all-cause mortality in 72,935 patients with a diagnosis of HIT between 2016–2020.
Adult patients with HIT were selected using the ICD-10 code D75.
82 (HIT) for inclusion and evaluated by demographic, clinical, and hospital characteristics.
Odds ratios were calculated for continuous variables using 95% confidence intervals.
Multivariable logistic regression was used to ascertain the odds of binary clinical outcomes relative to patient and hospital characteristics as well as the odds of clinical outcomes over time.
Results
Our analysis indicates that hospitalized patients with HIT are at 5 times higher odds of mortality than in those without HIT (OR: 5.
42, 95% CI: 5.
15–5.
71, p < 0.
001).
Our data also indicates significantly higher odds of HIT-associated mortality based on patient age, gender, and ethnicity.
By age, HIT patients at the highest risk of mortality were found to be between ages 46–60 (Odds Ratio (OR): 2.
60, 95% CI: 1.
58–4.
25), p < 0.
001).
By gender, females with HIT are at significantly lower odds of mortality compared to males (OR: 0.
90, 95% CI: 0.
82–0.
99, p < 0.
001).
By ethnicity, Hispanic patients are at the highest risk of mortality (OR: 1.
52, 95% CI: 1.
31–1.
77, p < 0.
001), followed by black patients (OR: 1.
45, 95% CI: 1.
27–1.
66, p < 0.
001), and then Asian patients (OR: 1.
31, 95% CI: 1.
00-1.
72, p = 0.
05).
Conclusion
HIT remains a clinical diagnosis based on quantitative criteria such as thrombocytopenia relative to baseline and timing of platelet decline but does not take into consideration other clinical variables that may stratify patients by increased risk.
This study elucidates the relationship between host-dependent risk factors such as age, gender, and ethnicity, on the risk of all-cause mortality associated with HIT.
Related Results
Case Report: Maggots' Infestation As a Predisposing Condition for Heparin-Induced Thrombocytopenia, a Newest Entity
Case Report: Maggots' Infestation As a Predisposing Condition for Heparin-Induced Thrombocytopenia, a Newest Entity
Abstract
Introduction
Thromobocytopenia is a well-recognized complication of heparin with risk of venous or arterial thrombosis. Heparin induced throm...
HEPARIN STIMULATES FIBROBLAST GROWTH INDUCED BY PDGF
HEPARIN STIMULATES FIBROBLAST GROWTH INDUCED BY PDGF
Heparin binds to smooth muscle cells and endothelial cells. It inhibits the proliferation of the smooth muscle cells and modulates the growth of endothelial cells. Fibroblasts whic...
SEVERE THROMBOCYTOPENIA POST PCI: HEPARIN-INDUCED VS GP IIB/IIIA INHIBITOR-INDUCED
SEVERE THROMBOCYTOPENIA POST PCI: HEPARIN-INDUCED VS GP IIB/IIIA INHIBITOR-INDUCED
Background: Thrombocytopenia is a clinically relevant complication in patients undergoing Percutaneous Coronary Intervention (PCI) or treated for Acute Coronary Syndrome (ACS), par...
Incidence of Antibodies to Protamine/Heparin Complexes in Cardiac Surgery Patients and Impact on Platelet Activation in Vitro and Clinical Outcome
Incidence of Antibodies to Protamine/Heparin Complexes in Cardiac Surgery Patients and Impact on Platelet Activation in Vitro and Clinical Outcome
Abstract
Abstract 2217
Introduction, aims of the study:
Cardiac surgery (CS) is associated with high risk of anti...
Unfractionated heparin may improve near-term survival in patients admitted to the ICU with sepsis attributed to pneumonia: an observational study using the MIMIC-IV database
Unfractionated heparin may improve near-term survival in patients admitted to the ICU with sepsis attributed to pneumonia: an observational study using the MIMIC-IV database
IntroductionLimited data are available on the use, duration, and dosage of anticoagulant therapy in patients with pneumonia-induced sepsis, and the survival benefits of heparin rem...
Bleeding in neonates with severe thrombocytopenia: a retrospective cohort study
Bleeding in neonates with severe thrombocytopenia: a retrospective cohort study
Abstract
Background
Severe neonatal thrombocytopenia is a rare disease with multiple etiologies. Severe thrombocytopenia with bleeding is life-threa...
Frequency of Thrombocytopenia in Malaria and its prognostic significance
Frequency of Thrombocytopenia in Malaria and its prognostic significance
BACKGROUND & OBJECTIVE: Thrombocytopenia is a common hematological manifestation of malaria, but locally there is limited data on the association of thrombocytopenia degree and...
Autoimmune Heparin-Induced Thrombocytopenia
Autoimmune Heparin-Induced Thrombocytopenia
Autoimmune thrombocytopenia (aHIT) is a severe subtype of heparin-induced thrombocytopenia (HIT) with atypical clinical features caused by highly pathological IgG antibodies (“aHIT...

